The global Circulating Tumor Cells (CTC) Liquid Biopsy market size was valued at USD 1126.7 million in 2022 and is forecast to a readjusted size of USD 2668.9 million by 2029 with a CAGR of 13.1% during review period.
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
This report is a detailed and comprehensive analysis for global Circulating Tumor Cells (CTC) Liquid Biopsy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Circulating Tumor Cells (CTC) Liquid Biopsy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Circulating Tumor Cells (CTC) Liquid Biopsy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Circulating Tumor Cells (CTC) Liquid Biopsy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Circulating Tumor Cells (CTC) Liquid Biopsy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Circulating Tumor Cells (CTC) Liquid Biopsy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Circulating Tumor Cells (CTC) Liquid Biopsy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
QIAGEN
Bio-Techne
Precision Medical
Aviva Systems Biological
Biocept
Fluxion Biosciences
Greiner Bio-One International GmbH
Ikonisys
Miltenyi Biotec
IVDiagnostics
BioFluidica
Canopus Medical
Biolidics
Creativ MicroTech
LungLife AI
Epic Sciences
Rarecells Diagnostics
ScreenCell
Menarini Silicon Biosystems
Kits & Reagents
Blood Collection Tubes
Devices
Research & Academic Institutes
Hospitals
Physician Laboratories
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Circulating Tumor Cells (CTC) Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Circulating Tumor Cells (CTC) Liquid Biopsy, with revenue, gross margin and global market share of Circulating Tumor Cells (CTC) Liquid Biopsy from 2018 to 2023.
Chapter 3, the Circulating Tumor Cells (CTC) Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Circulating Tumor Cells (CTC) Liquid Biopsy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Circulating Tumor Cells (CTC) Liquid Biopsy.
Chapter 13, to describe Circulating Tumor Cells (CTC) Liquid Biopsy research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cells (CTC) Liquid Biopsy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Circulating Tumor Cells (CTC) Liquid Biopsy by Type
1.3.1 Overview: Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Type in 2022
1.3.3 Kits & Reagents
1.3.4 Blood Collection Tubes
1.3.5 Devices
1.4 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market by Application
1.4.1 Overview: Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Research & Academic Institutes
1.4.3 Hospitals
1.4.4 Physician Laboratories
1.4.5 Others
1.5 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size & Forecast
1.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast by Region
1.6.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region, (2018-2029)
1.6.3 North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.6 South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 QIAGEN
2.1.1 QIAGEN Details
2.1.2 QIAGEN Major Business
2.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.1.4 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 QIAGEN Recent Developments and Future Plans
2.2 Bio-Techne
2.2.1 Bio-Techne Details
2.2.2 Bio-Techne Major Business
2.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.2.4 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Techne Recent Developments and Future Plans
2.3 Precision Medical
2.3.1 Precision Medical Details
2.3.2 Precision Medical Major Business
2.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.3.4 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Precision Medical Recent Developments and Future Plans
2.4 Aviva Systems Biological
2.4.1 Aviva Systems Biological Details
2.4.2 Aviva Systems Biological Major Business
2.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.4.4 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aviva Systems Biological Recent Developments and Future Plans
2.5 Biocept
2.5.1 Biocept Details
2.5.2 Biocept Major Business
2.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.5.4 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Biocept Recent Developments and Future Plans
2.6 Fluxion Biosciences
2.6.1 Fluxion Biosciences Details
2.6.2 Fluxion Biosciences Major Business
2.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.6.4 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Fluxion Biosciences Recent Developments and Future Plans
2.7 Greiner Bio-One International GmbH
2.7.1 Greiner Bio-One International GmbH Details
2.7.2 Greiner Bio-One International GmbH Major Business
2.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.7.4 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Greiner Bio-One International GmbH Recent Developments and Future Plans
2.8 Ikonisys
2.8.1 Ikonisys Details
2.8.2 Ikonisys Major Business
2.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.8.4 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ikonisys Recent Developments and Future Plans
2.9 Miltenyi Biotec
2.9.1 Miltenyi Biotec Details
2.9.2 Miltenyi Biotec Major Business
2.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.9.4 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Miltenyi Biotec Recent Developments and Future Plans
2.10 IVDiagnostics
2.10.1 IVDiagnostics Details
2.10.2 IVDiagnostics Major Business
2.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.10.4 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 IVDiagnostics Recent Developments and Future Plans
2.11 BioFluidica
2.11.1 BioFluidica Details
2.11.2 BioFluidica Major Business
2.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.11.4 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BioFluidica Recent Developments and Future Plans
2.12 Canopus Medical
2.12.1 Canopus Medical Details
2.12.2 Canopus Medical Major Business
2.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.12.4 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Canopus Medical Recent Developments and Future Plans
2.13 Biolidics
2.13.1 Biolidics Details
2.13.2 Biolidics Major Business
2.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.13.4 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biolidics Recent Developments and Future Plans
2.14 Creativ MicroTech
2.14.1 Creativ MicroTech Details
2.14.2 Creativ MicroTech Major Business
2.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.14.4 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Creativ MicroTech Recent Developments and Future Plans
2.15 LungLife AI
2.15.1 LungLife AI Details
2.15.2 LungLife AI Major Business
2.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.15.4 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 LungLife AI Recent Developments and Future Plans
2.16 Epic Sciences
2.16.1 Epic Sciences Details
2.16.2 Epic Sciences Major Business
2.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.16.4 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Epic Sciences Recent Developments and Future Plans
2.17 Rarecells Diagnostics
2.17.1 Rarecells Diagnostics Details
2.17.2 Rarecells Diagnostics Major Business
2.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.17.4 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Rarecells Diagnostics Recent Developments and Future Plans
2.18 ScreenCell
2.18.1 ScreenCell Details
2.18.2 ScreenCell Major Business
2.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.18.4 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 ScreenCell Recent Developments and Future Plans
2.19 Menarini Silicon Biosystems
2.19.1 Menarini Silicon Biosystems Details
2.19.2 Menarini Silicon Biosystems Major Business
2.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
2.19.4 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Menarini Silicon Biosystems Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Circulating Tumor Cells (CTC) Liquid Biopsy by Company Revenue
3.2.2 Top 3 Circulating Tumor Cells (CTC) Liquid Biopsy Players Market Share in 2022
3.2.3 Top 6 Circulating Tumor Cells (CTC) Liquid Biopsy Players Market Share in 2022
3.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Region Footprint
3.3.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Application (2018-2023)
5.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast by Application (2024-2029)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2029)
6.2 North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2029)
6.3 North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
6.3.1 North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2018-2029)
6.3.2 United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
6.3.3 Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
6.3.4 Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2029)
7.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2029)
7.3 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
7.3.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2018-2029)
7.3.2 Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.3 France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.5 Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
7.3.6 Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2018-2029)
8.3.2 China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.3 Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.4 South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.5 India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
8.3.7 Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
9 South America
9.1 South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2029)
9.2 South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2029)
9.3 South America Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
9.3.1 South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2018-2029)
9.3.2 Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
9.3.3 Argentina Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2018-2029)
10.3.2 Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
10.3.4 UAE Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Drivers
11.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market Restraints
11.3 Circulating Tumor Cells (CTC) Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Circulating Tumor Cells (CTC) Liquid Biopsy Industry Chain
12.2 Circulating Tumor Cells (CTC) Liquid Biopsy Upstream Analysis
12.3 Circulating Tumor Cells (CTC) Liquid Biopsy Midstream Analysis
12.4 Circulating Tumor Cells (CTC) Liquid Biopsy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. QIAGEN Company Information, Head Office, and Major Competitors
Table 6. QIAGEN Major Business
Table 7. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 8. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. QIAGEN Recent Developments and Future Plans
Table 10. Bio-Techne Company Information, Head Office, and Major Competitors
Table 11. Bio-Techne Major Business
Table 12. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 13. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bio-Techne Recent Developments and Future Plans
Table 15. Precision Medical Company Information, Head Office, and Major Competitors
Table 16. Precision Medical Major Business
Table 17. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 18. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Precision Medical Recent Developments and Future Plans
Table 20. Aviva Systems Biological Company Information, Head Office, and Major Competitors
Table 21. Aviva Systems Biological Major Business
Table 22. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 23. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Aviva Systems Biological Recent Developments and Future Plans
Table 25. Biocept Company Information, Head Office, and Major Competitors
Table 26. Biocept Major Business
Table 27. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 28. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Biocept Recent Developments and Future Plans
Table 30. Fluxion Biosciences Company Information, Head Office, and Major Competitors
Table 31. Fluxion Biosciences Major Business
Table 32. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 33. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Fluxion Biosciences Recent Developments and Future Plans
Table 35. Greiner Bio-One International GmbH Company Information, Head Office, and Major Competitors
Table 36. Greiner Bio-One International GmbH Major Business
Table 37. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 38. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Greiner Bio-One International GmbH Recent Developments and Future Plans
Table 40. Ikonisys Company Information, Head Office, and Major Competitors
Table 41. Ikonisys Major Business
Table 42. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 43. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Ikonisys Recent Developments and Future Plans
Table 45. Miltenyi Biotec Company Information, Head Office, and Major Competitors
Table 46. Miltenyi Biotec Major Business
Table 47. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 48. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Miltenyi Biotec Recent Developments and Future Plans
Table 50. IVDiagnostics Company Information, Head Office, and Major Competitors
Table 51. IVDiagnostics Major Business
Table 52. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 53. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. IVDiagnostics Recent Developments and Future Plans
Table 55. BioFluidica Company Information, Head Office, and Major Competitors
Table 56. BioFluidica Major Business
Table 57. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 58. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BioFluidica Recent Developments and Future Plans
Table 60. Canopus Medical Company Information, Head Office, and Major Competitors
Table 61. Canopus Medical Major Business
Table 62. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 63. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Canopus Medical Recent Developments and Future Plans
Table 65. Biolidics Company Information, Head Office, and Major Competitors
Table 66. Biolidics Major Business
Table 67. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 68. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Biolidics Recent Developments and Future Plans
Table 70. Creativ MicroTech Company Information, Head Office, and Major Competitors
Table 71. Creativ MicroTech Major Business
Table 72. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 73. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Creativ MicroTech Recent Developments and Future Plans
Table 75. LungLife AI Company Information, Head Office, and Major Competitors
Table 76. LungLife AI Major Business
Table 77. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 78. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. LungLife AI Recent Developments and Future Plans
Table 80. Epic Sciences Company Information, Head Office, and Major Competitors
Table 81. Epic Sciences Major Business
Table 82. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 83. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Epic Sciences Recent Developments and Future Plans
Table 85. Rarecells Diagnostics Company Information, Head Office, and Major Competitors
Table 86. Rarecells Diagnostics Major Business
Table 87. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 88. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Rarecells Diagnostics Recent Developments and Future Plans
Table 90. ScreenCell Company Information, Head Office, and Major Competitors
Table 91. ScreenCell Major Business
Table 92. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 93. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. ScreenCell Recent Developments and Future Plans
Table 95. Menarini Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 96. Menarini Silicon Biosystems Major Business
Table 97. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product and Solutions
Table 98. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Menarini Silicon Biosystems Recent Developments and Future Plans
Table 100. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue (USD Million) by Players (2018-2023)
Table 101. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Share by Players (2018-2023)
Table 102. Breakdown of Circulating Tumor Cells (CTC) Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Circulating Tumor Cells (CTC) Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Circulating Tumor Cells (CTC) Liquid Biopsy Players
Table 105. Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Type Footprint
Table 106. Circulating Tumor Cells (CTC) Liquid Biopsy Market: Company Product Application Footprint
Table 107. Circulating Tumor Cells (CTC) Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 108. Circulating Tumor Cells (CTC) Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Share by Type (2018-2023)
Table 111. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Forecast by Type (2024-2029)
Table 112. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2023)
Table 113. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Forecast by Application (2024-2029)
Table 114. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Circulating Tumor Cells (CTC) Liquid Biopsy Raw Material
Table 145. Key Suppliers of Circulating Tumor Cells (CTC) Liquid Biopsy Raw Materials
List of Figures
Figure 1. Circulating Tumor Cells (CTC) Liquid Biopsy Picture
Figure 2. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Type in 2022
Figure 4. Kits & Reagents
Figure 5. Blood Collection Tubes
Figure 6. Devices
Figure 7. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Application in 2022
Figure 9. Research & Academic Institutes Picture
Figure 10. Hospitals Picture
Figure 11. Physician Laboratories Picture
Figure 12. Others Picture
Figure 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Region in 2022
Figure 18. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Share by Players in 2022
Figure 24. Circulating Tumor Cells (CTC) Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Circulating Tumor Cells (CTC) Liquid Biopsy Market Share in 2022
Figure 26. Global Top 6 Players Circulating Tumor Cells (CTC) Liquid Biopsy Market Share in 2022
Figure 27. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Share by Type (2018-2023)
Figure 28. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share Forecast by Type (2024-2029)
Figure 29. Global Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Share by Application (2018-2023)
Figure 30. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Share Forecast by Application (2024-2029)
Figure 31. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 41. France Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 48. China Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 51. India Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Circulating Tumor Cells (CTC) Liquid Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 65. Circulating Tumor Cells (CTC) Liquid Biopsy Market Drivers
Figure 66. Circulating Tumor Cells (CTC) Liquid Biopsy Market Restraints
Figure 67. Circulating Tumor Cells (CTC) Liquid Biopsy Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Circulating Tumor Cells (CTC) Liquid Biopsy in 2022
Figure 70. Manufacturing Process Analysis of Circulating Tumor Cells (CTC) Liquid Biopsy
Figure 71. Circulating Tumor Cells (CTC) Liquid Biopsy Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
